{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T22:18:50Z","timestamp":1794694730240,"version":"4.9.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.clineuro.2026.109372","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:45:13Z","timestamp":1773215113000},"page":"109372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Glucagon-like peptide-1 receptor agonists and the risk of surgical intervention in idiopathic intracranial hypertension: A propensity-matched cohort study"],"prefix":"10.1016","volume":"265","author":[{"given":"Sean","family":"Kelleher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3878-5183","authenticated-orcid":false,"given":"Kyle","family":"Stump","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasad","family":"Kanuparthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6527-9725","authenticated-orcid":false,"given":"Theodore C.","family":"Hannah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Vij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bong-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clineuro.2026.109372_bib1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jocn.2021.11.029","article-title":"Idiopathic intracranial hypertension: pathophysiology, diagnosis and management","volume":"95","author":"Wang","year":"2022","journal-title":"J. Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109372_bib2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1474-4422(15)00298-7","article-title":"Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions","volume":"15","author":"Markey","year":"2016","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.clineuro.2026.109372_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/WNO.0000000000000448","article-title":"Obesity and weight loss in idiopathic intracranial hypertension: a narrative review","volume":"37","author":"Subramaniam","year":"2017","journal-title":"J. Neuroophthalmol."},{"issue":"4","key":"10.1016\/j.clineuro.2026.109372_bib4","first-page":"375","article-title":"Understanding the pathophysiology of idiopathic intracranial hypertension (IIH): a review of recent developments","volume":"95","author":"Colman","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"issue":"14","key":"10.1016\/j.clineuro.2026.109372_bib5","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1056\/NEJMra2404929","article-title":"Idiopathic intracranial hypertension","volume":"393","author":"Horton","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/j.clineuro.2026.109372_bib6","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/head.14776","article-title":"Arachnoid granulations in idiopathic intracranial hypertension: do they have an influence?","volume":"64","author":"Schievelkamp","year":"2024","journal-title":"Headache"},{"issue":"3","key":"10.1016\/j.clineuro.2026.109372_bib7","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/s41433-018-0238-5","article-title":"The expanding burden of idiopathic intracranial hypertension","volume":"33","author":"Mollan","year":"2019","journal-title":"Eye"},{"issue":"6","key":"10.1016\/j.clineuro.2026.109372_bib8","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1001\/jamaneurol.2021.0659","article-title":"Effectiveness of bariatric surgery vs community weight management intervention for the treatment of idiopathic intracranial hypertension: a randomized clinical trial","volume":"78","author":"Mollan","year":"2021","journal-title":"JAMA Neurol."},{"issue":"3","key":"10.1016\/j.clineuro.2026.109372_bib9","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1080\/13854046.2023.2249176","article-title":"A systematic review of cognition in idiopathic intracranial hypertension","volume":"38","author":"Richey","year":"2024","journal-title":"Clin. Neuropsychol."},{"issue":"5","key":"10.1016\/j.clineuro.2026.109372_bib10","first-page":"417","article-title":"Idiopathic Intracranial Hypertension: Evaluation of Admissions and Emergency Readmissions through the Hospital Episode Statistic Dataset between 2002-2020","volume":"11","author":"Mollan","year":"2021","journal-title":"Life (Basel)"},{"issue":"2","key":"10.1016\/j.clineuro.2026.109372_bib11","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s10143-020-01288-1","article-title":"A systematic review of surgical treatments of idiopathic intracranial hypertension (IIH)","volume":"44","author":"Kalyvas","year":"2021","journal-title":"Neurosurg. Rev."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109372_bib12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/02688697.2018.1538478","article-title":"Ventriculo-peritoneal shunting is a safe and effective treatment for idiopathic intracranial hypertension","volume":"33","author":"Bjornson","year":"2019","journal-title":"Br. J. Neurosurg."},{"key":"10.1016\/j.clineuro.2026.109372_bib13","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1016\/j.wneu.2021.03.134","article-title":"Dual antiplatelet therapy duration after venous sinus stenting for idiopathic intracranial hypertension and stent survival-is longer necessarily better? A meta-regression","volume":"151","author":"Sheriff","year":"2021","journal-title":"World Neurosurg."},{"issue":"2","key":"10.1016\/j.clineuro.2026.109372_bib14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.7326\/ANNALS-24-01590","article-title":"Efficacy and safety of glucagon-like peptide-1 receptor agonists for weight loss among adults without diabetes: a systematic review of randomized controlled trials","volume":"178","author":"Moiz","year":"2025","journal-title":"Ann. Intern Med."},{"issue":"4","key":"10.1016\/j.clineuro.2026.109372_bib15","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","article-title":"Mechanisms of action and therapeutic application of glucagon-like peptide-1","volume":"27","author":"Drucker","year":"2018","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.clineuro.2026.109372_bib16","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.pharmthera.2006.11.007","article-title":"Mechanisms of action of glucagon-like peptide 1 in the pancreas","volume":"113","author":"Doyle","year":"2007","journal-title":"Pharm. Ther."},{"issue":"4","key":"10.1016\/j.clineuro.2026.109372_bib17","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.2337\/db16-0755","article-title":"Glucagon-like peptide 1 and its analogs act in the dorsal raphe and modulate central serotonin to reduce appetite and body weight","volume":"66","author":"Anderberg","year":"2017","journal-title":"Diabetes"},{"issue":"404","key":"10.1016\/j.clineuro.2026.109372_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan0972","article-title":"A glucagon-like peptide-1 receptor agonist reduces intracranial pressure in a rat model of hydrocephalus","volume":"9","author":"Botfield","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.clineuro.2026.109372_bib19","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1093\/brain\/awad003","article-title":"The effect of GLP-1RA exenatide on idiopathic intracranial hypertension: a randomized clinical trial","volume":"146","author":"Mitchell","year":"2023","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.clineuro.2026.109372_bib20","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/jamaneurol.2025.2020","article-title":"GLP-1 receptor agonists in idiopathic intracranial hypertension","volume":"82","author":"Sioutas","year":"2025","journal-title":"JAMA Neurol."},{"issue":"4","key":"10.1016\/j.clineuro.2026.109372_bib21","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.3171\/2025.1.JNS242357","article-title":"Impact of GLP-1 receptor agonists on idiopathic intracranial hypertension clinical and neurosurgical outcomes: a propensity-matched multi-institutional cohort study","volume":"143","author":"O\u2019Leary","year":"2025","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.clineuro.2026.109372_bib22","unstructured":"TriNetX. The global health research network. Accessed August 8, 2025. \u3008https:\/\/trinetx.com\u3009."},{"issue":"1","key":"10.1016\/j.clineuro.2026.109372_bib23","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00701-016-3010-2","article-title":"Efficacy, complications and cost of surgical interventions for idiopathic intracranial hypertension: a systematic review of the literature","volume":"159","author":"Kalyvas","year":"2017","journal-title":"Acta Neurochir."},{"issue":"9","key":"10.1016\/j.clineuro.2026.109372_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/ene.70358","article-title":"Efficacy and Safety of GLP-1 and Dual GIP\/GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension: A Systematic Review and Meta-Analysis","volume":"32","author":"Stefanou","year":"2025","journal-title":"Eur J Neurol"},{"issue":"10","key":"10.1016\/j.clineuro.2026.109372_bib25","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1177\/0333102420928079","article-title":"Infectious and inflammatory disorders might increase the risk of developing idiopathic intracranial hypertension - a national case-control study","volume":"40","author":"Sundholm","year":"2020","journal-title":"Cephalalgia"},{"key":"10.1016\/j.clineuro.2026.109372_bib26","article-title":"The immunomodulatory effects of GLP-1 receptor agonists in neurogenerative diseases and ischemic stroke treatment","volume":"16","author":"Sun","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clineuro.2026.109372_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106320","article-title":"The anti-inflammatory and immunological properties of GLP-1 receptor agonists","volume":"182","author":"Bendotti","year":"2022","journal-title":"Pharm. Res."},{"issue":"9","key":"10.1016\/j.clineuro.2026.109372_bib28","doi-asserted-by":"crossref","DOI":"10.57264\/cer-2025-0083","article-title":"Affordable access to GLP-1 obesity medications: strategies to guide market action and policy solutions in the US","volume":"14","author":"Pearson","year":"2025","journal-title":"J. Comp. Eff. Res."},{"issue":"6","key":"10.1016\/j.clineuro.2026.109372_bib29","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11916-024-01215-9","article-title":"Idiopathic intracranial hypertension after abrupt cessation of medication: a case report of abrupt glucagon-like peptide-1 (GLP-1) receptor agonist cessation and review of the literature","volume":"28","author":"Heckel","year":"2024","journal-title":"Curr. Pain. Headache Rep."},{"issue":"2","key":"10.1016\/j.clineuro.2026.109372_bib30","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/WNO.0000000000000922","article-title":"Complications of ventriculoperitoneal shunt for idiopathic intracranial hypertension: a single-institution study of 32 patients","volume":"41","author":"Brune","year":"2021","journal-title":"J. Neuroophthalmol."},{"issue":"2","key":"10.1016\/j.clineuro.2026.109372_bib31","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/neuros\/nyz080","article-title":"Lumboperitoneal and ventriculoperitoneal shunting for idiopathic intracranial hypertension demonstrate comparable failure and complication rates","volume":"86","author":"Azad","year":"2020","journal-title":"Neurosurgery"},{"issue":"2","key":"10.1016\/j.clineuro.2026.109372_bib32","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.wneu.2013.01.096","article-title":"Long-term outcomes of ventriculoperitoneal shunt surgery in patients with hydrocephalus","volume":"81","author":"Reddy","year":"2014","journal-title":"World Neurosurg."},{"key":"10.1016\/j.clineuro.2026.109372_bib33","doi-asserted-by":"crossref","DOI":"10.1136\/jnis-2025-023699","article-title":"Transverse venous sinus stenting versus cerebrospinal fluid shunting in idiopathic intracranial hypertension: a multi-institutional and multinational database study","author":"Intrapiromkul","year":"2025","journal-title":"J. Neurointerv Surg."},{"key":"10.1016\/j.clineuro.2026.109372_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2024.122948","article-title":"Venous sinus stenting for idiopathic intracranial hypertension: an updated Meta-analysis","volume":"459","author":"Azzam","year":"2024","journal-title":"J. Neurol. Sci."},{"issue":"21","key":"10.1016\/j.clineuro.2026.109372_bib35","doi-asserted-by":"crossref","first-page":"e661","DOI":"10.1161\/CIR.0000000000000567","article-title":"Indications for the performance of intracranial endovascular neurointerventional procedures: a scientific statement from the american heart association","volume":"137","author":"Eskey","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.clineuro.2026.109372_bib36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3109\/01658107.2012.757787","article-title":"Long-term results of optic nerve sheath fenestration for idiopathic intracranial hypertension: earlier intervention favours improved outcomes","volume":"37","author":"Pineles","year":"2013","journal-title":"Neuroophthalmology"},{"issue":"4","key":"10.1016\/j.clineuro.2026.109372_bib37","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1212\/WNL.0000000000002318","article-title":"Overdiagnosis of idiopathic intracranial hypertension","volume":"86","author":"Fisayo","year":"2016","journal-title":"Neurology"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846726000648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846726000648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T08:48:51Z","timestamp":1775119731000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846726000648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":37,"alternative-id":["S0303846726000648"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2026.109372","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagon-like peptide-1 receptor agonists and the risk of surgical intervention in idiopathic intracranial hypertension: A propensity-matched cohort study","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2026.109372","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109372"}}